Sammy Parks DEA


Agents with the U.S. Drug Enforcement Administration on Wednesday seized more than 700 million pills and shuttered operations at a Sugar Land pharmaceutical distribution company as part of an opioid investigation, according to the administration.

No one has yet been criminally charged in connection to the seizure, and the raid happened because of a suspension order that resulted in all controlled substances being removed, said Sammy Parks, spokesperson for the Houston division of the DEA.

“Woodfield Distribution LLC has been and continues to maintain active discussions with the DEA to address areas of concern related to governance and oversight of business operations,” according to the company involved in the operation. “The alleged violations are being taken seriously by Woodfield Distribution LLC and every effort and attention is being made to resolve this situation in a timely and efficient manner for our clients in the near term.”

The company was founded in 2010 in Boca Raton, Florida and has offices and warehouses in Florida, Texas, New Jersey and Ohio, according to the company’s website. It specializes in supply chain and warehousing needs for prescription and over-the-counter medications, according to the website.

Investigators on Wednesday served the company three suspension orders that immediately suspended DEA registrations for failure to maintain efficient controls against the diversion of controlled substances, according to the administration.

The investigators seized all controlled substances, in part, because the company allegedly illegally imported more than 200 million opioid pills and didn’t properly account for more than five million pills, according to the DEA.

Agents during the investigation found the facility in Sugar Land allegedly stored millions of controlled substances in unsecured aisles and failed to report thefts and losses and allegedly falsified records, according to the DEA.

The seizure is possibly the largest in Fort Bend County history.

“This case unmistakably demonstrates DEA’s commitment to using all available tools to combat our nation’s opioid crisis and to ensure registrants remain compliant in DEA’s continued efforts to reduce the diversion of controlled substances and make our communities safer and healthier,” said Daniel Comeaux, the DEA’s special agent in charge for the Houston Division.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.